Top Research Publications: July 2023

Epidemiology

1. Gordon AJ, Saxon AJ, Kertesz S, Wyse JJ, Manhapra A, Lin LA, Chen W, Hansen J, Pinnell D, Huynh T, Baylis JD, Cunningham FE, Ghitza UE, Bart G, Yu H, Sauer BC. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug Alcohol Depend. 2023; 248: 109902. doi: 10.1016/j.drugalcdep.2023.109902.
2. Cannon-Albright LA, Teerlink CC, Stevens J, Facelli JC, Carr SR, Allen-Brady K, Puri S, Bailey-Wilson JE, Musolf AM, Akerley W. A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer. Int J Cancer. 2023; 153(2): 364-72. PMC10182245 doi: 10.1002/ijc.34510.
3. Kalvesmaki AF, Trevino AY, Charron E, Kroll-Desrosiers A, Peterson K, Pugh MJ. The Impact of Resilience on Employment Among Post-9/11 Veterans With and Without Military Sexual Trauma Exposure. Mil Med. 2023. doi: 10.1093/milmed/usad267.

Gastroenterology, Hepatology & Nutrition

1. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ. Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol. 2023 Jun 28:S1542-3565(23)00498-6. doi: 10.1016/j.cgh.2023.06.013. Online ahead of print. PMID: 37391057
2. Gupta S, Earles A, Bustamante R, Patterson OV, Gawron AJ, Kaltenbach TR, Yassin H, Lamm M, Shah SC, Saini SD, Fisher DA, Martinez ME, Messer K, Demb J, Liu L. Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1924-1936.e9. doi: 10.1016/j.cgh.2022.10.003. Epub 2022 Oct 19. PMID: 36270618 
3. Ramai D, Heaton J, Abomhya A, Morris J, Adler DG. Frailty Is Independently Associated with Higher Mortality and Readmissions in Patients with Acute Biliary Pancreatitis: A Nationwide Inpatient Study. Dig Dis Sci. 2023 Jun;68(6):2196-2203. doi: 10.1007/s10620-023-07830-7. Epub 2023 Jan 18. PMID: 36652048

Geriatrics

1. Ghazi, L, Shen, J, Ying, J, Derington, CG, Cohen, JB, Marcum, ZA, Herrick, JS, King, JB, Cheung, AK, Williamson, JD, Pajewski, NM, Bryan, N, Supiano, MA, Sonnen, J, Weintraub, WS, Greene, TH, Bress, AP  Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit - A Secondary Analysis of the SPRINT Randomized Clinical Trial JAMA Network Open 2023 May 19 6(5):e2314443 DOI: 10.1001/jamanetworkopen.2023.14443
2. Zheutlin, AR, Addo, DK, Jacobs, JA, Derington, CG, Herrick, JS, Greene, TH, Stulberg, EL, Berlowitz, DR, Williamson, JD, Pajewski, NM, Supiano, MA, Bress, AP. Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT Hypertension 2023 May 11 80:1484–1493 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.123.21323 PMID: 37165900

Infectious Disease

1. Imlay H, Seibert AM, Hanson KE. Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. Transpl Infect Dis. 2023 Apr;25(2):e14020. doi: 10.1111/tid.14020. Epub 2023 Jan 27. PMID: 36705292 Review.
2. Ahmed SM, Brintz BJ, Talbert A, Ngari M, Pavlinac PB, Platts-Mills JA, Levine AC, Nelson EJ, Walson JL, Kotloff KL, Berkley JA, Leung DT. Derivation and external validation of a clinical prognostic model identifying children at risk of death following presentation for diarrheal care. PLOS Glob Public Health. 2023 Jun 27;3(6):e0001937. doi: 10.1371/journal.pgph.0001937. 
3. Luther VP,  Barsoumian AE, Konold VJL, Vijayan T, Balba G, Benson C, Blackburn B  , Cariello P , Perlof S, Razonable R, Acharya K, Azar MM, Bhanot N,  Blyth D, Butt Saira, Casanas, B,  Chow B,  Cleveland K,  Cutrell   JB, Doshi, Finkel D, Graber CJ,  Hochberg NS ,  James SH , Kaltsas AQ,   Kodiyanplakkal  ,  Lee M, Marcos L,   Lora AJM ,  Moore CC,   Nnedu O, Osario G,    Paras ML,   Reece, NM Salas, Sansai-Bhola K, Shultz S,    Serpa JA,   Shnekendorf  R, Weisenberg S, Wooten D, Zuckerman RA, Melia M, Chirch LM Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors DOI: 10.1093/ofid/ofad289 PMID: 37397270 PMCID: PMC10313091 https://pubmed.ncbi.nlm.nih.gov/37397270/

Oncology

1. Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, De Giorgi U, Young Joung J, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Di Santo N, Zohren F, Fizazi K. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 2:S0140-6736(23)01055-3. doi: 10.1016/S0140-6736(23)01055-3. PMID: 37285865.
2. Florou V, Elliott A, Bailey MH, Stone D, Affolter K, Soares HP, Nevala-Plagemann C, Scaife C, Walker P, Korn WM, Lou E, Shroff RT, Hosein PJ, Garrido-Laguna I. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC)Unveils New Actionable Genomic Aberrations in PACC. Clin Cancer Res. 2023 Jun 2:CCR-22-3724. doi: 10.1158/1078-0432.CCR-22-3724. PMID: 37266563.
3. Rugo HS, Crossno CL, Gesthalter YB, Kelley K, Moore HB, Rimawi MF, Westbrook KE, Buys SS. Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2-Expressing Metastatic Breast Cancer. JCO Oncol Pract. 2023 May 19:OP2200480. doi: 10.1200/OP.22.00480. Online ahead of print.PMID: 37207306.